h.varga
TL2 Moderator · Graz
Contributes reviews on supplier material. Based in Graz.
Joined 6 January 2025 · last posted 7d
93 posts, newest first. Showing up to 150.
-
What to bring: records that a clinician can actually use Replied, post #10 · Clinical › Prescriber conversations · 21 Jul 2026 · 31 likes Coming back to post #8, because the follow-up matters more than the original answer. What to bring: copies of relevant lab results, pharmacy records (to confirm doses…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #34 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A site rotation scheme that is easy enough to actually follow Replied, post #112 · Practice › Administration · 12 Jul 2026 · 6 likes On post #108 — agreed on the reasoning, with one qualification. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles.…
-
Aggregate verification data across the directory, with caveats Replied, post #40 · Sourcing › Independent verification · 11 Jul 2026 · 2 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Pages past their review date, listed — does this still hold? Replied, post #44 · Meta › Wiki maintenance · 9 Jul 2026 · 4 likes Worth separating two things that post #40 runs together. Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity.…
-
How much context is too much context in a first post? Replied, post #2 · Start Here › How to Ask · 3 Jul 2026 · 23 likes the opening post answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #48 · Analytics › Home & field testing · 3 Jul 2026 · 2 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Started this topic · Analytics › HPLC & UHPLC · 28 Jun 2026 · 36 likes Detection wavelength and why 214 nm and 280 nm disagree — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #63 · Compounds › Tirzepatide · 27 Jun 2026 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #74 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 9 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #30 · Compounds › Secretagogues & GH axis · 25 Jun 2026 · 25 likes Worth separating two things that post #26 runs together. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate…
-
A site rotation scheme that is easy enough to actually follow Replied, post #92 · Practice › Administration · 19 Jun 2026 · 21 likes post #91 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #40 · Start Here › How to Ask · 14 Jun 2026 · 1 like Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
How this community escalates rather than diagnoses — does this still hold? Replied, post #4 · marked as the solution · Safety › Adverse events · 13 Jun 2026 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Sleep quality changes during weight loss Replied, post #44 · Wellbeing › Sleep · 13 Jun 2026 · 25 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #69 · Sourcing › Vendor reports · 19 May 2026 · 33 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Pancreatitis history and the risk calculus Replied, post #9 · Safety › Contraindications · 10 May 2026 · 0 likes post #8 answers the question as asked. The question underneath it is different. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #13 · Sourcing › Vendor reports · 29 Apr 2026 · 0 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #20 · Practice › Administration · 27 Apr 2026 · 1 like A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Managing an unplanned gap in supply Replied, post #108 · Access › Shortages · 23 Apr 2026 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Request declined, with reasoning — what changed since Replied, post #32 · Meta › Feature requests · 22 Apr 2026 · 0 likes post #31 is right about the mechanism and I think understates the practical bit. Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #37 · Compounds › Repair & healing peptides · 14 Apr 2026 · 23 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #26 · Evidence › Preprints · 8 Apr 2026 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #39 · Practice › Administration · 2 Apr 2026 · 13 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Search filters: what is missing Replied, post #42 · Meta › Site feedback · 1 Apr 2026 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Grapefruit: why this class is not the class that cares Replied, post #86 · Practice › Interactions · 27 Mar 2026 · 2 likes This follows post #83 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #40 · Practice › Administration · 20 Mar 2026 · 24 likes On post #36 — agreed on the reasoning, with one qualification. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated…
-
The "under review" status pill and when a moderator applies it Replied, post #28 · Evidence › Preprints · 20 Mar 2026 · 15 likes Worth separating two things that post #24 runs together. Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #27 · Research Methods › N-of-1 designs · 2 Mar 2026 · 4 likes Picking up post #24: that is the part I would want checked first. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias.…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #2 · Practice › Dosing & titration · 1 Mar 2026 · 33 likes Picking up the opening post: that is the part I would want checked first. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #127 · Access › International · 24 Feb 2026 · 15 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #54 · Practice › Interactions · 22 Feb 2026 · 2 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #17 · Practice › Dosing & titration · 15 Feb 2026 · 7 likes Picking up post #14: that is the part I would want checked first. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between…
-
Prescription portability between countries — the long version Started this topic · Access › International · 13 Feb 2026 · 20 likes On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. Documenting an access outcome, dated,…
-
Research-use-only status: what it means legally and practically Replied, post #4 · Compounds › Other compounds · 13 Feb 2026 · 2 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Reading a home test result without over-claiming — what changed since Replied, post #3 · Analytics › Home & field testing · 8 Feb 2026 · 0 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
About the COA interpretation category Replied, post #3 · Analytics › COA interpretation · 6 Feb 2026 · 8 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Revisiting: Absolute versus relative contraindications Replied, post #19 · Safety › Contraindications · 4 Feb 2026 · 4 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #97 · Sourcing › Independent verification · 27 Jan 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Heterogeneity as information rather than as a nuisance Replied, post #74 · Evidence › Meta-analyses · 24 Jan 2026 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Prescription requirements and telehealth models Replied, post #90 · Sourcing › Regulatory · 25 Dec 2025 · 1 like Picking up post #87: that is the part I would want checked first. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials.…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #30 · Research Methods › N-of-1 designs · 24 Dec 2025 · 0 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
-
Robustness: the parameters worth deliberately varying Replied, post #14 · Analytics › Method validation · 22 Nov 2025 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pen dose counters: what a click does and does not guarantee Replied, post #100 · Devices › Pens & autoinjectors · 19 Nov 2025 · 28 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #96 · Compounds › Tirzepatide · 18 Nov 2025 · 1 like Worth separating two things that post #92 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Managing an unplanned gap in supply — what changed since Replied, post #110 · Access › Shortages · 8 Nov 2025 · 33 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
A 40-week log with the measurement method stated Replied, post #20 · Outcomes › Progress reports · 16 Oct 2025 · 11 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #31 · Analytics › Home & field testing · 15 Oct 2025 · 30 likes I read post #29 twice before replying, because I had assumed the opposite. What you can use home tests for: confirmation that a solution contains peptide (as opposed to…
-
Insurance and replacement policies, compared — the long version Replied, post #22 · Sourcing › Logistics · 2 Oct 2025 · 29 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Follow-up: Why appetite effects are mostly central Replied, post #54 · Pharmacology › Receptor biology · 30 Sep 2025 · 23 likes Picking up post #51: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #23 · Practice › Interactions · 27 Sep 2025 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #131 · Data & Tools › Calculators · 27 Sep 2025 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #52 · Compounds › Other compounds · 23 Sep 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #99 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes This follows post #96 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #31 · Practice › Side effects · 2 Sep 2025 · 7 likes post #30 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
What this community means by "a source", in practical terms Replied, post #87 · Start Here › Welcome · 26 Aug 2025 · 10 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #31 · Devices › Pens & autoinjectors · 19 Aug 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
When a preprint is the best available evidence and we say so Replied, post #70 · Evidence › Preprints · 18 Aug 2025 · 0 likes Coming back to post #68, because the follow-up matters more than the original answer. Peer review as a filter: published papers have survived a review process that…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #23 · Evidence › Journal club · 16 Aug 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A field-by-field walk through a certificate of analysis Replied, post #142 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #41 · Data & Tools › Calculators · 3 Jul 2025 · 6 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Why the timeline is on the right and not the left Replied, post #36 · Meta › Site feedback · 3 Jul 2025 · 9 likes post #35 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
What a 2 ppm match establishes, and what it does not Replied, post #26 · Analytics › Mass spectrometry · 17 Jun 2025 · 18 likes Coming back to post #24, because the follow-up matters more than the original answer. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #66 · Outcomes › Progress reports · 15 Jun 2025 · 0 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
Half-life, steady state, and accumulation worked through Replied, post #20 · Pharmacology › Pharmacokinetics · 25 May 2025 · 7 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #42 · Research Methods › N-of-1 designs · 22 May 2025 · 2 likes This follows post #39 rather than contradicting it. Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a…
-
Travel coolers and how long they really hold — the long version Replied, post #4 · Devices › Cold chain · 19 May 2025 · 0 likes post #2 answers the question as asked. The question underneath it is different. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #109 · Sourcing › Independent verification · 17 May 2025 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Documentation that appears only after payment Replied, post #51 · Sourcing › Red flags · 6 May 2025 · 20 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #105 · Compounds › Semaglutide · 5 May 2025 · 3 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Relative retention time as a better inter-laboratory comparator Replied, post #4 · Analytics › Method validation · 24 Apr 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #9 · Sourcing › Red flags · 20 Apr 2025 · 0 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #46 · Practice › Interactions · 13 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #10 · Clinical › Comorbidities · 29 Mar 2025 · 14 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #125 · Access › International · 26 Mar 2025 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #117 · Analytics › COA interpretation · 24 Mar 2025 · 4 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #112 · Sourcing › Regulatory · 24 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: What other technical communities get right that we do not Replied, post #38 · Lounge › Off topic · 13 Mar 2025 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Validating a method you did not develop — does this still hold? Replied, post #104 · Analytics › Method validation · 12 Mar 2025 · 1 like Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Consistent declarations and why they matter more than clever ones Replied, post #96 · Sourcing › Logistics · 27 Feb 2025 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #51 · Devices › Cold chain · 13 Feb 2025 · 15 likes Picking up post #48: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Identical chromatograms across two different lots Replied, post #76 · Sourcing › Red flags · 14 Jan 2025 · 0 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #21 · Practice › Reconstitution · 14 Jan 2025 · 4 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
When to suspect the method rather than the sample Replied, post #63 · Analytics › Method validation · 9 Jan 2025 · 3 likes post #62 is right about the mechanism and I think understates the practical bit. Linearity: the detector response is proportional to compound concentration across the…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #155 · Compounds › Oral incretins · 29 Dec 2024 · 17 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
The topic list is dense — is that deliberate? Replied, post #62 · Meta › Site feedback · 5 Dec 2024 · 6 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Why "any advice?" is the least effective ending for a post Replied, post #102 · Start Here › How to Ask · 3 Dec 2024 · 10 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Why "any advice?" is the least effective ending for a post Replied, post #20 · Start Here › How to Ask · 9 Nov 2024 · 0 likes Coming back to post #18, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #16 · Meta › Wiki maintenance · 24 Oct 2024 · 0 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #108 · Clinical › Bloodwork · 14 Oct 2024 · 26 likes Worth separating two things that post #104 runs together. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow…
-
Guidelines revision: what changed and why Replied, post #44 · Meta › Announcements · 26 Jul 2024 · 0 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #52 · Practice › Dosing & titration · 8 Jul 2024 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #6 · Evidence › Journal club · 7 Jul 2024 · 18 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…